{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:24:52Z","timestamp":1740173092680,"version":"3.37.3"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcte.2024.100367","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T18:22:50Z","timestamp":1725646970000},"page":"100367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients"],"prefix":"10.1016","volume":"37","author":[{"given":"Lind","family":"Alexander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai","family":"Cheng-ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lernmark","family":"\u00c5ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jendle","family":"Johan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcte.2024.100367_b0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"32","key":"10.1016\/j.jcte.2024.100367_b0010","doi-asserted-by":"crossref","first-page":"50835","DOI":"10.18632\/oncotarget.10615","article-title":"Leukocyte telomere length and mortality risk in patients with type 2 diabetes","volume":"7","author":"Bonfigli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcte.2024.100367_b0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diabres.2018.04.041","article-title":"White blood cells count as an indicator to identify whether obesity leads to increased risk of type 2 diabetes","volume":"141","author":"Gu","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"7591","key":"10.1016\/j.jcte.2024.100367_b0020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"issue":"15 Suppl","key":"10.1016\/j.jcte.2024.100367_b0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/dom.12167","article-title":"Islet autoimmunity in phenotypic type 2 diabetes patients","volume":"3","author":"Brooks-Worrell","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcte.2024.100367_b0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fendo.2019.00451","article-title":"Type 2 diabetes: how much of an autoimmune disease?","volume":"10","author":"de Candia","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8020","key":"10.1016\/j.jcte.2024.100367_b0035","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(77)91258-2","article-title":"Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents","volume":"1","author":"Irvine","year":"1977","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jcte.2024.100367_b0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/dme.12700","article-title":"Latent autoimmune diabetes of the adult: current knowledge and uncertainty","volume":"32","author":"Laugesen","year":"2015","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.jcte.2024.100367_b0045","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1530\/EC-19-0379","article-title":"Prevalence of positive islet autoantibody in type 2 diabetes patients: a cross-sectional study in a Chinese community","volume":"8","author":"Gao","year":"2019","journal-title":"Endocr Connect"},{"issue":"3","key":"10.1016\/j.jcte.2024.100367_b0050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1464-5491.1994.tb00275.x","article-title":"Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency","volume":"11","author":"Zimmet","year":"1994","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.jcte.2024.100367_b0055","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: A consensus statement from an international expert panel","volume":"69","author":"Buzzetti","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2024.100367_b0060","article-title":"Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19","author":"Alexander","year":"2023","journal-title":"Diab Epidemiol Manage"},{"key":"10.1016\/j.jcte.2024.100367_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113265","article-title":"Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease","volume":"506","author":"Lind","year":"2022","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.jcte.2024.100367_b0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1021\/acscentsci.5b00340","article-title":"Ultrasensitive antibody detection by agglutination-PCR (ADAP)","volume":"2","author":"Tsai","year":"2016","journal-title":"ACS Cent Sci"},{"issue":"6","key":"10.1016\/j.jcte.2024.100367_b0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/2472630320950663","article-title":"Sensitive and specific detection of SARS-CoV-2 antibodies using a high-throughput, fully automated liquid-handling robotic system","volume":"25","author":"Karp","year":"2020","journal-title":"SLAS Technol"},{"issue":"1","key":"10.1016\/j.jcte.2024.100367_b0080","doi-asserted-by":"crossref","first-page":"20188","DOI":"10.1038\/s41598-020-76913-6","article-title":"A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots","volume":"10","author":"Karp","year":"2020","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.jcte.2024.100367_b0085","doi-asserted-by":"crossref","first-page":"e0242049","DOI":"10.1371\/journal.pone.0242049","article-title":"Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR","volume":"15","author":"Cortez","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jcte.2024.100367_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5603\/EP.a2016.0017","article-title":"Endocrine autoimmunity in patients with Latent Autoimmune Diabetes in Adults (LADA) - association with HLA genotype","volume":"67","author":"Szepietowska","year":"2016","journal-title":"Endokrynol Pol"},{"issue":"8","key":"10.1016\/j.jcte.2024.100367_b0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/08916934.2018.1547711","article-title":"Islet autoantibody positivity in overweight and obese adults with type 2 diabetes","volume":"51","author":"Pilla","year":"2018","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.jcte.2024.100367_b0100","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/diacare.25.6.995","article-title":"Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study)","volume":"25","author":"Takeda","year":"2002","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcte.2024.100367_b0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/dc08-1468","article-title":"Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Tr\u00f8ndelag Health (HUNT) study","volume":"32","author":"Radtke","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jcte.2024.100367_b0110","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2337\/dc12-0931","article-title":"Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7","volume":"36","author":"Hawa","year":"2013","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jcte.2024.100367_b0115","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.2337\/dc18-1069","article-title":"Individuals fulfilling criteria for type 2 diabetes rather than LADA display transient signs of autoimmunity preceding diagnosis with possible clinical implications: The HUNT study","volume":"41","author":"S\u00f8rgjerd","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jcte.2024.100367_b0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/08820138809049846","article-title":"The significance of natural autoantibodies","volume":"17","author":"Tomer","year":"1988","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jcte.2024.100367_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.815703","article-title":"The prevalence of islet autoantibodies in children and adolescents with type 1 diabetes mellitus: A global scoping review","volume":"13","author":"Ross","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.jcte.2024.100367_b0130","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/pedi.13209","article-title":"Clinical features, biochemistry, and HLA-DRB1 status in youth-onset type 1 diabetes in Sudan","volume":"22","author":"Ibrahim","year":"2021","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"10.1016\/j.jcte.2024.100367_b0135","doi-asserted-by":"crossref","first-page":"e0268783","DOI":"10.1371\/journal.pone.0268783","article-title":"Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda","volume":"17","author":"Kibirige","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jcte.2024.100367_b0140","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jdiacomp.2016.05.005","article-title":"Islet cell-associated autoantibodies in Ethiopians with diabetes mellitus","volume":"30","author":"Siraj","year":"2016","journal-title":"J Diab Compl"},{"issue":"10","key":"10.1016\/j.jcte.2024.100367_b0145","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1007\/s00125-020-05229-x","article-title":"Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia","volume":"63","author":"Balcha","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcte.2024.100367_b0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-2557-4-4","article-title":"Islet cell autoantibodies in African patients with Type 1 and Type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study","volume":"4","author":"Lutale","year":"2007","journal-title":"J Autoimmune Dis"},{"issue":"1","key":"10.1016\/j.jcte.2024.100367_b0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabres.2013.11.013","article-title":"Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients","volume":"103","author":"Asanghanwa","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.jcte.2024.100367_b0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.jcte.2024.100367_b0165","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/db06-0552","article-title":"T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes","volume":"56","author":"Goel","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jcte.2024.100367_b0170","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/diabetes.48.5.983","article-title":"Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients","volume":"48","author":"Brooks-Worrell","year":"1999","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jcte.2024.100367_b0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/dc10-0579","article-title":"Identification of autoantibody-negative autoimmune type 2 diabetic patients","volume":"34","author":"Brooks-Worrell","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcte.2024.100367_b0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00125-019-05016-3","article-title":"Autoimmunity plays a role in the onset of diabetes after 40 years of age","volume":"63","author":"Rolandsson","year":"2020","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.jcte.2024.100367_b0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.48.1.150","article-title":"Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies","volume":"48","author":"Tuomi","year":"1999","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.jcte.2024.100367_b0190","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/er.2018-00163","article-title":"Thyroid dysfunction and diabetes mellitus: two closely associated disorders","volume":"40","author":"Biondi","year":"2019","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.jcte.2024.100367_b0195","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2011.03976.x","article-title":"High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults","volume":"74","author":"Jin","year":"2011","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.jcte.2024.100367_b0200","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00125-005-1690-x","article-title":"Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)","volume":"48","author":"Davis","year":"2005","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.jcte.2024.100367_b0205","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s001250100548","article-title":"The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes","volume":"44","author":"Wilkin","year":"2001","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.jcte.2024.100367_b0210","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2337\/dc16-0293","article-title":"Inverse relationship between organ-specific autoantibodies and systemic immune mediators in type 1 diabetes and type 2 diabetes: action LADA 11","volume":"39","author":"Schloot","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcte.2024.100367_b0215","doi-asserted-by":"crossref","first-page":"1061671","DOI":"10.3389\/fendo.2022.1061671","article-title":"Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity","volume":"13","author":"Chyli\u0144ska-Fr\u0105tczak","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.jcte.2024.100367_b0220","doi-asserted-by":"crossref","first-page":"e3055","DOI":"10.1002\/dmrr.3055","article-title":"Evidence of diabetes-specific autoimmunity in obese subjects with normal glucose tolerance","volume":"34","author":"Tiberti","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"10.1016\/j.jcte.2024.100367_b0225","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2337\/dc06-1696","article-title":"High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes","volume":"30","author":"Buzzetti","year":"2007","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jcte.2024.100367_b0230","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.2337\/db22-0360","article-title":"Islet autoantibody levels differentiate progression trajectories in individuals with presymptomatic type 1 diabetes","volume":"71","author":"Kwon","year":"2022","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.jcte.2024.100367_b0235","doi-asserted-by":"crossref","first-page":"e4341","DOI":"10.1210\/clinem\/dgac507","article-title":"Islet autoantibody level distribution in type 1 diabetes and their association with genetic and clinical characteristics","volume":"107","author":"Grace","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jcte.2024.100367_b0240","doi-asserted-by":"crossref","first-page":"e3137","DOI":"10.1002\/dmrr.3137","article-title":"Immunological and clinical characteristics of latent autoimmune diabetes in the elderly","volume":"35","author":"Yohena","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.jcte.2024.100367_b0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diabetes.49.1.32","article-title":"Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes","volume":"49","author":"Pietropaolo","year":"2000","journal-title":"Diabetes"},{"issue":"9087","key":"10.1016\/j.jcte.2024.100367_b0250","first-page":"1288","article-title":"UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes","volume":"350","author":"Turner","year":"1997","journal-title":"UK Prospect Diab Study Group Lancet"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623724000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T02:52:34Z","timestamp":1726800754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623724000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":50,"alternative-id":["S2214623724000383"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100367","relation":{},"ISSN":["2214-6237"],"issn-type":[{"type":"print","value":"2214-6237"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2024.100367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100367"}}